NIA | Technology Transfer

The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

United Kingdom
12783752.4
Filed on 2012-10-15

The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

France
12783752.4
Filed on 2012-10-15

The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Germany
12783752.4
Filed on 2012-10-15

METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE

Read more about METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE

South Korea
10-2021-7022385
Filed on 2021-07-15

The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

European Patent
21177619.0
Filed on 2021-06-03

METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES

Read more about METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES

US Patent 11,389,415
Filed on 2020-08-13

METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS

Read more about METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS

Hong Kong
17105381.7
Filed on 2017-05-29

METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS

Read more about METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS

Japan
2016-547580
Filed on 2015-01-21

METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS

Read more about METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS

European Patent
15704412.4
Filed on 2015-01-21

USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN

Read more about USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN

US Application 16/945,163
Filed on 2020-07-31

Subscribe to NIA